Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Tranylcypromine (2-PCPA) hydrochloride

🥰Excellent
Catalog No. T1025Cas No. 1986-47-6
Alias Tranylcypromine (2-PCPA) HCl, SKF-385 HCl

Tranylcypromine (2-PCPA) hydrochloride (SKF-385 HCl), a Monoamine Oxidase inhibitor, is effective in the treatment of major depression, dysthymic disorder, and atypical depression.

Tranylcypromine (2-PCPA) hydrochloride

Tranylcypromine (2-PCPA) hydrochloride

🥰Excellent
Purity: 97.19%
Catalog No. T1025Alias Tranylcypromine (2-PCPA) HCl, SKF-385 HClCas No. 1986-47-6
Tranylcypromine (2-PCPA) hydrochloride (SKF-385 HCl), a Monoamine Oxidase inhibitor, is effective in the treatment of major depression, dysthymic disorder, and atypical depression.
Pack SizePriceAvailabilityQuantity
100 mg$39In Stock
200 mg$51In Stock
1 mL x 10 mM (in DMSO)$39In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "Tranylcypromine (2-PCPA) hydrochloride"

Select Batch
Purity:97.19%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Tranylcypromine (2-PCPA) hydrochloride (SKF-385 HCl), a Monoamine Oxidase inhibitor, is effective in the treatment of major depression, dysthymic disorder, and atypical depression.
Targets&IC50
MAO-B:7 μM, MAO-A:11.5 μM, LSD1:22.3 μM
In vitro
Compared with the control group, Tranylcypromine at dosages of 5 mg/kg and 10 mg/kg significantly and gradually increased muscle activity in male rats; however, a 2 mg/kg dosage of Tranylcypromine had no effect. Additionally, Tranylcypromine administered at 10 mg/kg markedly increased the number of copulatory behaviors in male rats.
In vivo
In bovine aortic endothelial cells, Tranylcypromine (500 μg/mL) markedly inhibits bradykinin-induced release of arachidonic acid. Additionally, Tranylcypromine suppresses the activity of CYP2A6 (IC50: 0.42 μM) and CYP2E1 (IC50: 3 μM) in human liver microsomes (HLMs), inducing type II and cyclopropylbenzene type I difference spectra in HLMs. Nicotine metabolism mediated by CYP2A6 in HLMs is completely inhibited by R-(+)-Tranylcypromine (Ki: 0.05 μM), (±)-Tranylcypromine (Ki: 0.08 μM), and S-(-)-Tranylcypromine (Ki: 2.0 μM).
Kinase Assay
PDE activity is determined with some modifications. The assay mixture contain 50 mM Tris (pH 7.4), 5 mM MgCl2, 0.5 μM cAMP or cGMP, and [3H]cAMP or [3H]cGMP (about 30,000 cpm/assay), the indicated concentration of the inhibitor and an aliquot of the enzyme solution at a final assay volume of 200 μL. Stock solutions of the compounds are diluted 1:100 (v/v) in the Tris buffer mentioned above; appropriate dilutions are prepared in 1% (v/v) DMSO/Tris buffer, which are diluted 1:2 (v/v) in the assays to obtain the desired final concentrations of the inhibitors at a DMSO concentration of 0.5% (v/v). DMSO itself affected none of the PDE activities. After preincubation for 5 min at 37°C, the reaction is started by the addition of substrate (cAMP or cGMP) and the assays are incubated for further 15 min at 37°C. Then 50 μL of 0.2 N HCl is added to stop the reaction and the assays are left on ice for about 10 min. Following incubation with 25 μg of 5′-nucleotidase (Crotalus atrox snake venom) for 10 min at 37°C, the assays are loaded on QAE Sephadex A-25 (1 mL of bed volume in Poly-Prep chromatography columns). The columns are eluted with 2 mL of 30 mM ammonium formate (pH 6.0) and the eluate is counted for radioactivity. Results are corrected for blank values (measured in the presence of denatured protein) that are below 5% of total radioactivity. The amount of cyclic nucleotides hydrolyzed did not exceed 30% of the original substrate concentration[3].
AliasTranylcypromine (2-PCPA) HCl, SKF-385 HCl
Chemical Properties
Molecular Weight169.66
FormulaC9H11N·HCl
Cas No.1986-47-6
SmilesN[C@H]1[C@H](C2=CC=CC=C2)C1.Cl
Relative Density.no data available
Storage & Solubility Information
Storagestore under nitrogen,store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
H2O: 17 mg/mL (100 mM)
DMSO: 65 mg/mL (383.12 mM)
Solution Preparation Table
H2O/DMSO
1mg5mg10mg50mg
1 mM5.8941 mL29.4707 mL58.9414 mL294.7071 mL
5 mM1.1788 mL5.8941 mL11.7883 mL58.9414 mL
10 mM0.5894 mL2.9471 mL5.8941 mL29.4707 mL
20 mM0.2947 mL1.4735 mL2.9471 mL14.7354 mL
50 mM0.1179 mL0.5894 mL1.1788 mL5.8941 mL
100 mM0.0589 mL0.2947 mL0.5894 mL2.9471 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Tranylcypromine (2-PCPA) hydrochloride | purchase Tranylcypromine (2-PCPA) hydrochloride | Tranylcypromine (2-PCPA) hydrochloride cost | order Tranylcypromine (2-PCPA) hydrochloride | Tranylcypromine (2-PCPA) hydrochloride chemical structure | Tranylcypromine (2-PCPA) hydrochloride in vivo | Tranylcypromine (2-PCPA) hydrochloride in vitro | Tranylcypromine (2-PCPA) hydrochloride formula | Tranylcypromine (2-PCPA) hydrochloride molecular weight